Abstract
The nuclear factor I (NFI) family of transcription factors play an important role in normal development of multiple organs. Three NFI family members are highly expressed in the brain, and deletions or sequence variants in two of these, NFIA and NFIX, have been associated with intellectual disability (ID) and brain malformations. NFIB, however, has not previously been implicated in human disease. Here, we present a cohort of 18 individuals with mild ID and behavioral issues who are haploinsufficient for NFIB. Ten individuals harbored overlapping microdeletions of the chromosomal 9p23-p22.2 region, ranging in size from 225 kb to 4.3 Mb. Five additional subjects had point sequence variations creating a premature termination codon, and three subjects harbored single-nucleotide variations resulting in an inactive protein as determined using an in vitro reporter assay. All individuals presented with additional variable neurodevelopmental phenotypes, including muscular hypotonia, motor and speech delay, attention deficit disorder, autism spectrum disorder, and behavioral abnormalities. While structural brain anomalies, including dysgenesis of corpus callosum, were variable, individuals most frequently presented with macrocephaly. To determine whether macrocephaly could be a functional consequence of NFIB disruption, we analyzed a cortex-specific Nfib conditional knockout mouse model, which is postnatally viable. Utilizing magnetic resonance imaging and histology, we demonstrate that Nfib conditional knockout mice have enlargement of the cerebral cortex but preservation of overall brain structure and interhemispheric connectivity. Based on our findings, we propose that haploinsufficiency of NFIB causes ID with macrocephaly.
Original language | English (US) |
---|---|
Pages (from-to) | 752-768 |
Number of pages | 17 |
Journal | American Journal of Human Genetics |
Volume | 103 |
Issue number | 5 |
DOIs | |
State | Published - Nov 1 2018 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by grants from the National Health and Medical Research Council Australia ( GNT1100443 to L.J.R.), the French Ministry of Health (PHRC national 2008/2008-A00515-50 ), Regional Council of Burgundy/Dijon University hospital ( PARI 2012 ), The Genesis Foundation for Children , the US National Institutes of Health under NINDS grants ( 1R01NS092772 and 234567890 to W.B.D.; 1R01NS058721 to W.B.D. and E.H.S.; and K08NS092898 to G.M.M.), and Jordan’s Guardian Angels (G.M.M.). J.W.C.L. was supported by an International Postgraduate Research Scholarship and UQ Centennial Scholarship . R.M.G. was supported by NYSTEM grants ( C026714 , C026429 , and C030133 ). R.J.D. was supported by Brain Injured Children’s Aftercare Recovery Endeavours (BICARE) Fellowship. L.J.R. was supported by an NHMRC Principal Research Fellowship ( GNT1005751 ). M.Z. was supported by a grant from the German Ministry of Education and Research (BMBF) ( GeNeRARe 01GM1519A ). We acknowledge the Linkage Infrastructure, Equipment and Facilities (LIEF) grant ( LE100100074 ) awarded to the Queensland Brain Institute for the Slide Scanner and the facilities of the National Imaging Facility (NIF) at the Centre for Advanced Imaging, University of Queensland, used in the animal experiments. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources.
Funding Information:
This work was supported by grants from the National Health and Medical Research Council Australia (GNT1100443 to L.J.R.), the French Ministry of Health (PHRC national 2008/2008-A00515-50), Regional Council of Burgundy/Dijon University hospital (PARI 2012), The Genesis Foundation for Children, the US National Institutes of Health under NINDS grants (1R01NS092772 and 234567890 to W.B.D.; 1R01NS058721 to W.B.D. and E.H.S.; and K08NS092898 to G.M.M.), and Jordan's Guardian Angels (G.M.M.). J.W.C.L. was supported by an International Postgraduate Research Scholarship and UQ Centennial Scholarship. R.M.G. was supported by NYSTEM grants (C026714, C026429, and C030133). R.J.D. was supported by Brain Injured Children's Aftercare Recovery Endeavours (BICARE) Fellowship. L.J.R. was supported by an NHMRC Principal Research Fellowship (GNT1005751). M.Z. was supported by a grant from the German Ministry of Education and Research (BMBF) (GeNeRARe 01GM1519A). We acknowledge the Linkage Infrastructure, Equipment and Facilities (LIEF) grant (LE100100074) awarded to the Queensland Brain Institute for the Slide Scanner and the facilities of the National Imaging Facility (NIF) at the Centre for Advanced Imaging, University of Queensland, used in the animal experiments. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources.
Publisher Copyright:
© 2018 American Society of Human Genetics
Keywords
- NFIB
- agenesis of the corpus callosum
- chromosome 9p22.3
- chromosome 9p23
- developmental delay
- haploinsufficiency
- intellectual disability
- macrocephaly
- megalencephaly
- nuclear factor I